争议事件
以下收录公开来源中与该品牌相关的争议事件。列出一条并不表示过错已经证实。
返回词条共 2 条
2026
患者就与Mounjaro和Trulicity相关的胃部问题起诉礼来
提起诉讼
据《Indiana Lawyer》报道,一名患者起诉礼来(Eli Lilly),称其胃部问题与药物Mounjaro和Trulicity有关。该事件于2026年10月8日被报道。诉讼涉及该患者声称的与这两种药物相关的胃部问题。来源未提供有关结果或其他指控的进一步细节。
当事方说明的目的. 阻止假冒瑞他鲁肽的销售
品牌回应
否认 — Eli Lilly
In an emailed statement, a spokesperson for Eli Lilly called the complaint “baseless”
否认 — CVS
Spokespersons for CVS and Novo Nordisk said they intend to “vigorously defend” against the claims in the lawsuit.
否认 — Novo Nordisk
Spokespersons for CVS and Novo Nordisk said they intend to “vigorously defend” against the claims in the lawsuit.
否认 — Sanofi
Sanofi said its pricing practices have “always complied with the law.”
来源摘录
Eli Lilly sued over stomach problems patient ties to Mounjaro and Trulicity
Caleb Amick, The Indiana Lawyer
On Aug. 12, Eli Lilly announced it had filed six lawsuits against companies that it claims are illegally selling retatrutide.
2026
礼来前销售代表因涉嫌推广Mounjaro提起诉讼
提起诉讼
礼来前销售代表Jennifer Mansion起诉该公司,称她反对礼来涉嫌将Mounjaro用于减重的推广后遭到报复。诉状称该用途当时尚未获批。报复指控仍属指称,并非已确立的法院认定。
来源摘录
An alleged Mounjaro marketing dispute is at the center of former Eli Lilly and Co. sales representative Jennifer Mansion's lawsuit, which accuses the company of retaliation after she objected.
Mansion's complaint dates the end of her employment to Nov. 9, 2023. It says she had objected to Lilly's alleged promotion of Mounjaro for weight loss.
The complaint describes weight loss as a use that had not been approved at the time. The retaliation charge remains Mansion's allegation and is not an established court finding.